| 2024 |
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family” |
Articolo in rivista |
Go to |
| 2024 |
On-treatment dynamics of circulating extracellular vesicles in the first-line setting of patients with advanced non-small cell lung cancer: the LEXOVE prospective study. |
Articolo in rivista |
Go to |
| 2024 |
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients |
Articolo in rivista |
Go to |
| 2024 |
Exploring the potential of multiomics liquid biopsy testing in the clinical setting of lung cancer |
Articolo in rivista |
Go to |
| 2024 |
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors |
Review essay (rassegna critica) |
Go to |
| 2024 |
BRCA-associated hereditary male cancers: can gender affect the prevalence and spectrum of germline pathogenic variants? |
Articolo in rivista |
Go to |
| 2024 |
Polθ: emerging synthetic lethal partner in homologous recombination-deficient tumors |
Review essay (rassegna critica) |
Go to |
| 2023 |
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) |
Articolo in rivista |
Go to |
| 2023 |
Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis |
Review essay (rassegna critica) |
Go to |
| 2023 |
The role of bone modifying agents for secondary osteoporosis prevention and pain control in post-menopausal osteopenic breast cancer patients undergoing adjuvant aromatase inhibitors |
Articolo in rivista |
Go to |
| 2023 |
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study |
Articolo in rivista |
Go to |
| 2023 |
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay |
Articolo in rivista |
Go to |
| 2023 |
The significance of tissue-agnostic biomarkers in solid tumors: the more the merrier? |
Articolo in rivista |
Go to |
| 2023 |
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab |
Articolo in rivista |
Go to |
| 2023 |
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one? |
Articolo in rivista |
Go to |
| 2023 |
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window? |
Articolo in rivista |
Go to |
| 2023 |
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer |
Articolo in rivista |
Go to |
| 2022 |
Early detection screening: myth or reality? |
Capitolo o Saggio |
Go to |
| 2022 |
Safety and effectiveness of gemcitabine for the treatment of classic Kaposi’s sarcoma without visceral involvement |
Articolo in rivista |
Go to |
| 2022 |
Liquid biopsy: a right tool in a right context? |
Capitolo o Saggio |
Go to |
| 2022 |
Molecular tumor board |
Capitolo o Saggio |
Go to |
| 2022 |
Liquid biopsy and immunotherapy: is all that glitter gold? |
Capitolo o Saggio |
Go to |
| 2022 |
Current clinically validated applications of liquid biopsy |
Capitolo o Saggio |
Go to |
| 2022 |
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer? |
Articolo in rivista |
Go to |
| 2022 |
Navigating the liquid biopsy Minimal Residual Disease (MRD) in non-small cell lung cancer: Making the invisible visible |
Articolo in rivista |
Go to |
| 2022 |
MUTYH-associated tumor syndrome: The other face of MAP |
Articolo in rivista |
Go to |
| 2022 |
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors? |
Articolo in rivista |
Go to |
| 2022 |
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer |
Articolo in rivista |
Go to |
| 2022 |
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning |
Articolo in rivista |
Go to |
| 2022 |
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength |
Articolo in rivista |
Go to |
| 2022 |
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors |
Articolo in rivista |
Go to |
| 2022 |
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis |
Articolo in rivista |
Go to |
| 2022 |
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study |
Articolo in rivista |
Go to |
| 2022 |
Future perspectives |
Capitolo o Saggio |
Go to |
| 2021 |
Type and gene location of kit mutations predict progression-free survival to first-line imatinib in gastrointestinal stromal tumors: A look into the exon |
Articolo in rivista |
Go to |
| 2021 |
Role of the HIPPO pathway as potential key player in the cross talk between oncology and cardiology |
Articolo in rivista |
Go to |
| 2021 |
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors |
Review essay (rassegna critica) |
Go to |
| 2021 |
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome |
Articolo in rivista |
Go to |
| 2021 |
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs) |
Articolo in rivista |
Go to |
| 2021 |
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials |
Articolo in rivista |
Go to |
| 2021 |
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes |
Review essay (rassegna critica) |
Go to |
| 2021 |
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma |
Recensione in rivista |
Go to |
| 2021 |
Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?—A trial-level meta-analysis in PD-L1 selected subgroups |
Articolo in rivista |
Go to |
| 2021 |
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses |
Articolo in rivista |
Go to |
| 2021 |
Prognostic role of plasma pd‐1, pd‐l1, pan‐btn3as and btn3a1 in patients affected by metastatic gastrointestinal stromal tumors: Can immune checkpoints act as a sentinel for short‐term survival? |
Articolo in rivista |
Go to |
| 2021 |
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge |
Articolo in rivista |
Go to |
| 2020 |
The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal |
Review essay (rassegna critica) |
Go to |
| 2020 |
Moving the target on the optimal adjuvant strategy for resected pancreatic cancers: A systematic review with meta-analysis |
Articolo in rivista |
Go to |
| 2020 |
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 |
Articolo in rivista |
Go to |
| 2020 |
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score |
Articolo in rivista |
Go to |
| 2020 |
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions |
Articolo in rivista |
Go to |
| 2020 |
2020 Reply to: Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials |
Lettera |
Go to |
| 2020 |
The emerging therapeutic landscape of alk inhibitors in non-small cell lung cancer |
Review essay (rassegna critica) |
Go to |
| 2020 |
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients |
Articolo in rivista |
Go to |
| 2020 |
A “lymphocyte microrna signature” as predictive biomarker of immunotherapy response and plasma pd-1/pd-l1 expression levels in patients with metastatic renal cell carcinoma: Pointing towards epigenetic reprogramming |
Articolo in rivista |
Go to |
| 2020 |
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes |
Articolo in rivista |
Go to |
| 2019 |
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? |
Review essay (rassegna critica) |
Go to |
| 2019 |
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients |
Articolo in rivista |
Go to |
| 2019 |
One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients |
Articolo in rivista |
Go to |
| 2019 |
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in metastatic melanoma patients? |
Abstract in atti di convegno pubblicato in rivista |
Go to |
| 2019 |
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis |
Articolo in rivista |
Go to |
| 2019 |
An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesistargeting TKI-based therapy |
Articolo in rivista |
Go to |
| 2019 |
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial |
Articolo in rivista |
Go to |
| 2019 |
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis |
Articolo in rivista |
Go to |
| 2019 |
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma? |
Articolo in rivista |
Go to |
| 2019 |
How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials |
Articolo in rivista |
Go to |
| 2019 |
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1 |
Articolo in rivista |
Go to |
| 2019 |
Correction to: One shot NEPA plus dexamethasone to prevent chemotherapy-induced nausea and vomiting (CINV) in sarcoma patients receiving multiple-day chemotherapy (Supportive Care in Cancer, (2019), 27, 9, (3593-3597), 10.1007/s00520-019-4645-3) |
Nota o commento |
Go to |
| 2019 |
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) |
Review essay (rassegna critica) |
Go to |
| 2019 |
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials |
Articolo in rivista |
Go to |
| 2018 |
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis |
Articolo in rivista |
Go to |
| 2018 |
Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizumab |
Articolo in rivista |
Go to |
| 2018 |
Erratum to: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis (Scientific Reports, (2018), 8, 1, (13379), 10.1038/s41598-018-30780-4) |
Nota o commento |
Go to |
| 2018 |
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis |
Articolo in rivista |
Go to |
| 2018 |
Monoclonal antibodies for the treatment of non-hematological tumors: a safety review |
Articolo in rivista |
Go to |
| 2018 |
Circular RNA in Exosomes |
Capitolo o Saggio |
Go to |
| 2017 |
EGFR inhibition in NSCLC: New findings…. and opened questions? |
Articolo in rivista |
Go to |
| 2017 |
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors |
Articolo in rivista |
Go to |
| 2017 |
Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway |
Articolo in rivista |
Go to |
| 2017 |
Technical Aspects for the Evaluation of Circulating Nucleic Acids (CNAs): Circulating Tumor DNA (ctDNA) and Circulating MicroRNAs |
Capitolo o Saggio |
Go to |
| 2017 |
Technical Aspects for the Evaluation of Circulating Tumor Cells (CTCs) |
Capitolo o Saggio |
Go to |
| 2017 |
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin |
Articolo in rivista |
Go to |
| 2017 |
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials |
Articolo in rivista |
Go to |
| 2017 |
Potential miRNAs involved in molecular pathways mediating the anticancer effects of short term starvation in breast cancer cells treated with doxorubicin |
Abstract in atti di convegno pubblicato in rivista |
Go to |
| 2017 |
Galectin-3 in acute coronary syndrome |
Review essay (rassegna critica) |
Go to |
| 2016 |
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? |
Articolo in rivista |
Go to |
| 2016 |
A headlight on liquid biopsies: a challenging tool for breast cancer management |
Articolo in rivista |
Go to |
| 2016 |
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway |
Review essay (rassegna critica) |
Go to |
| 2016 |
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus |
Articolo in rivista |
Go to |
| 2016 |
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma |
Articolo in rivista |
Go to |
| 2016 |
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis |
Articolo in rivista |
Go to |
| 2016 |
Nintedanib in NSCLC: Evidence to date and place in therapy |
Articolo in rivista |
Go to |
| 2016 |
Beyond evidence-based data: Scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma |
Articolo in rivista |
Go to |
| 2016 |
Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis |
Articolo in rivista |
Go to |
| 2016 |
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status |
Articolo in rivista |
Go to |
| 2016 |
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? |
Articolo in rivista |
Go to |
| 2016 |
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines |
Proceedings |
Go to |
| 2016 |
Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer |
Capitolo o Saggio |
Go to |
| 2016 |
Non-coding RNAs functioning in colorectal cancer stem cells |
Capitolo o Saggio |
Go to |
| 2016 |
The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? |
Articolo in rivista |
Go to |
| 2016 |
Dietary restriction: could it be considered as speed bump on tumor progression road? |
Articolo in rivista |
Go to |
| 2015 |
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy |
Articolo in rivista |
Go to |
| 2015 |
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? |
Articolo in rivista |
Go to |
| 2015 |
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario |
Articolo in rivista |
Go to |
| 2015 |
Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers |
Proceedings |
Go to |
| 2015 |
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment |
Articolo in rivista |
Go to |
| 2015 |
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? |
Articolo in rivista |
Go to |
| 2015 |
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? |
Articolo in rivista |
Go to |
| 2015 |
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy |
Review essay (rassegna critica) |
Go to |
| 2014 |
Utility of laser microdissection and pressure catapulting in the diagnosis of non small cell lung cancer: preliminary data. |
Articolo in rivista |
Go to |
| 2014 |
Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? |
Articolo in rivista |
Go to |
| 2014 |
Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer |
Articolo in rivista |
Go to |
| 2014 |
Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy? |
Articolo in rivista |
Go to |
| 2014 |
Ramucirumab and its use in gastric cancer treatment |
Articolo in rivista |
Go to |
| 2013 |
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations |
Articolo in rivista |
Go to |
| 2013 |
Monoclonal antibodies in gastrointestinal cancers |
Articolo in rivista |
Go to |
| 2013 |
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. |
Articolo in rivista |
Go to |
| 2013 |
The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? |
Articolo in rivista |
Go to |
| 2013 |
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. |
Articolo in rivista |
Go to |
| 2013 |
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions |
Articolo in rivista |
Go to |
| 2013 |
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets |
Articolo in rivista |
Go to |
| 2013 |
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines |
Articolo in rivista |
Go to |
| 2013 |
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? |
Articolo in rivista |
Go to |
| 2012 |
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells |
Articolo in rivista |
Go to |
| 2012 |
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? |
Articolo in rivista |
Go to |
| 2012 |
Breast cancer genome-wide association studies: there is strength in numbers |
Articolo in rivista |
Go to |
| 2012 |
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies |
Articolo in rivista |
Go to |
| 2012 |
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? |
Articolo in rivista |
Go to |
| 2012 |
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? |
Articolo in rivista |
Go to |
| 2011 |
Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors |
Articolo in rivista |
Go to |
| 2010 |
The long and winding road to useful predictive factors for anti-egfr therapy in metastatic colorectal carcinoma: The KRAS/BRAF pathway |
Articolo in rivista |
Go to |
| 2010 |
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE |
Abstract in rivista |
Go to |
| 2010 |
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy? |
Articolo in rivista |
Go to |
| 2010 |
Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma |
Articolo in rivista |
Go to |
| 2010 |
miR-20b Modulates VEGF
Expression by Targeting HIF-1a
and STAT3 in MCF-7 Breast
Cancer Cells |
Articolo in rivista |
Go to |
| 2010 |
A non common BRAF mutation c1799-1801 delTGA identified in sporadic colon rectal cancer of sicilian patients |
Abstract in atti di convegno pubblicato in rivista |
Go to |
| 2010 |
Anti-endothelin drugs in solid tumors |
Articolo in rivista |
Go to |
| 2010 |
VUS variants in BRCA genes of hereditary breast/ovarian cancer |
Proceedings |
Go to |
| 2009 |
Male breast cancer. |
Articolo in rivista |
Go to |
| 2009 |
Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation? |
Articolo in rivista |
Go to |
| 2009 |
the proximal leptin gene promoter is regulated by ppar gamma agonist in MCF-7 and MDA-MB-231 breast cancer cells |
Proceedings |
Go to |
| 2009 |
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling |
Abstract in rivista |
Go to |
| 2009 |
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations |
Abstract in rivista |
Go to |
| 2009 |
Expression of angiogenic regulators. VEGF and leptin, is regulated by the EGF/P13K/STAT3 pathway in colorectal cancer cells |
Articolo in rivista |
Go to |
| 2009 |
Hereditary ovarian cancer |
Articolo in rivista |
Go to |
| 2009 |
Expression of angiogenic regulators, VEGF and leptin, is regulated by the
EGF/PI3K/STAT3 pathway in colorectal cancer cells. |
Articolo in rivista |
Go to |
| 2009 |
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell |
Abstract in rivista |
Go to |
| 2009 |
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare:
strategie di prevenzione nelle donne ad alto
rischio |
Capitolo o Saggio |
Go to |
| 2009 |
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells |
Abstract in rivista |
Go to |
| 2009 |
New insight on immunological activation pathways of
Langerhans cells, possible tolerogenic role |
Capitolo o Saggio |
Go to |
| 2009 |
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles |
Abstract in rivista |
Go to |
| 2008 |
Gists eredo familiari e pediatrici: aspetti biomolecolari e clinici. |
Capitolo o Saggio |
Go to |
| 2008 |
La consulenza genetica in oncologia: implicazioni biomolecolari e cliniche. |
Articolo in rivista |
Go to |
| 2007 |
Genotype analysis of colorectal carcinomas through laser pressare catapulting (LPC) |
Proceedings |
Go to |
| 2007 |
Carcinoma ereditario dell'ovaio (Ereditary Ovarian Cancer) |
Capitolo o Saggio |
Go to |
| 2007 |
BRCA 1/2 VARIANTS OF UNCERTAIN CLINICAL SIGNIFICANCE IN PATIENTS WITH FAMILIAL AND HEREDITARY BREAST/OVARIAN CANCER |
Proceedings |
Go to |
| 2007 |
Reelin expression in human prostate cancer: a marker of tumor aggressiveness based on correlation with grade. |
Articolo in rivista |
Go to |
| 2007 |
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES |
Proceedings |
Go to |
| 2007 |
The role of Aurora-A inhibitors in cancer therapy. |
Articolo in rivista |
Go to |
| 2007 |
BRCA1/BRCA2 genes mutational screening in Sicilian breast and/or ovarian cancer families. |
Proceedings |
Go to |
| 2007 |
Aberrant methylation within RUNX3 CpG island associated with the nuclear and
mitochondrial microsatellite instability in sporadic gastric cancers. Results of
a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. |
Articolo in rivista |
Go to |
| 2007 |
GENOTYPE ANALYSIS OF COLORECTAL CARCINOMAS THROUGH LASER PRESSURE CATAPULTING (LPC) |
Proceedings |
Go to |
| 2007 |
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus. |
Articolo in rivista |
Go to |
| 2007 |
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. |
Articolo in rivista |
Go to |
| 2007 |
High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier
probability. |
Articolo in rivista |
Go to |
| 2007 |
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC) |
Proceedings |
Go to |
| 2007 |
Expression level of the mammaglobin (MGB1) gene in BC:possibile index of BC progression |
Proceedings |
Go to |
| 2007 |
TP53, Ki-Ras and P16INK4A gene molecular analysis in salivary gland tumors. |
Proceedings |
Go to |
| 2007 |
Founder mutations in BRCA1 and BRCA2 genes |
Articolo in rivista |
Go to |
| 2007 |
TP53, H-K-RAS, P16INK4A GENE MOLECULAR ANALYSIS IN SALIVARY GLAND TUMORS |
Proceedings |
Go to |
| 2007 |
Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence. |
Articolo in rivista |
Go to |
| 2007 |
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). |
Articolo in rivista |
Go to |
| 2007 |
Analysis of TP53, Ki-Ras and P16INK4A promoter methylation as potential prognostic factors in patients with colorectal cancer |
Proceedings |
Go to |
| 2007 |
Aplotype analysis in four sicilian families with 5083del19bp-BRCA1. |
Proceedings |
Go to |
| 2007 |
Patterns of genomic instability in gastric cancer: clinical implications and perspectives. |
Articolo in rivista |
Go to |
| 2007 |
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes. |
Proceedings |
Go to |
| 2006 |
TP53, h-k-ras,p16ink4a gene molecular analysis in salivary gland tumors |
Proceedings |
Go to |
| 2006 |
P16 ink4A, p53 alterations and S phase fraction are predictive of clinical outcome in laryngeal squamous cell carcinoma. |
Proceedings |
Go to |
| 2006 |
Ductal lavage: a valid method of risk assessment and of early diagnosis in breast cancer. |
Proceedings |
Go to |
| 2006 |
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. |
Articolo in rivista |
Go to |
| 2006 |
A study of a new germline mutation in BRCA1 gene in two Sicilian families: a founder mutation? |
Proceedings |
Go to |
| 2006 |
Ductal lavage: a way of carefully tracing the breast-secreting duct |
Articolo in rivista |
Go to |
| 2006 |
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a
Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite
instability status and country of origin. |
Articolo in rivista |
Go to |
| 2006 |
TP 53, H-K-Ras, P16INK4A gene molecular analysis in salivary gland tumors. |
Proceedings |
Go to |
| 2006 |
A missense mutation associated to early onset breast cancer in a sicilian woman. |
Proceedings |
Go to |
| 2006 |
BRCA1 germline mutations in Sicilian breast and/or ovarian cancer families and their implications for genetic counselling. |
Proceedings |
Go to |
| 2006 |
Apoptosis: a relevant tool for anticancer therapy. |
Articolo in rivista |
Go to |
| 2006 |
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. |
Articolo in rivista |
Go to |
| 2006 |
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. |
Articolo in rivista |
Go to |
| 2006 |
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study |
Articolo in rivista |
Go to |
| 2006 |
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma |
Articolo in rivista |
Go to |
| 2006 |
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study |
Articolo in rivista |
Go to |
| 2006 |
TP53 mutations and microsatellite instability are prognostic factors in gastric cancer? |
Proceedings |
Go to |
| 2006 |
Q356R and S1512I are BRCA1 variants that may be associated with breast cancer in a Sicilian family. |
Proceedings |
Go to |
| 2006 |
BRCA1 missense variants of uncertain clinical significance in unaffected and breast/ovarian cancer of the Sicilian population. |
Proceedings |
Go to |
| 2006 |
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. |
Articolo in rivista |
Go to |
| 2006 |
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. |
Articolo in rivista |
Go to |
| 2006 |
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and
progression of pleomorphic adenomas. |
Articolo in rivista |
Go to |
| 2005 |
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC
(RASCAL) and TP53CRC collaborative studies. |
Articolo in rivista |
Go to |
| 2005 |
A.Mutational analysis of BRCA1 in sicilian patients at risk for inherited of reference center for the biomolecular characterizaztion of neoplasm and genetic screening of hereditary tumors |
Proceedings |
Go to |
| 2005 |
TP53 in exon 5 and s-Phase fraction but not mutations in Ras gen family and DNA-ploidy are indipendent indicators in laryngeal squamous cell carcinoma |
Proceedings |
Go to |
| 2005 |
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical
outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo
Oncologico dell'Italia Meridionale (GOIM) prospective study. |
Articolo in rivista |
Go to |
| 2005 |
TP53 mutations and S-Phase fraction are independent prognostic indicators in locally advanced laryngeal squamous cell carcinoma |
Altro |
Go to |
| 2005 |
Pharmacogenomics in colorectal carcinomas: Future perspectives in personalized therapy |
Articolo in rivista |
Go to |
| 2005 |
TP53 Mutation in exon 5 and S-Phase Fraction but not Mutations in Ras gene family and DNA-ploidy are Indipendent prognostic indicators in Laryngeal Squamous Cell Carcinoma |
Proceedings |
Go to |
| 2005 |
Laser Pressure Catapulting (LPC): Optimization LPC-System and Genotyping of Colorectal Carcinomas |
Articolo in rivista |
Go to |
| 2005 |
TP53 mutations are not prognostic independent indicators in bladder cancer. |
Proceedings |
Go to |
| 2005 |
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment |
Articolo in rivista |
Go to |
| 2005 |
Detection of free-circulating tumor DNA in plasma of patients with gastrointestinal cancer. |
Proceedings |
Go to |
| 2005 |
Le basi scientifiche della cancerogenesi: “up-date” |
Capitolo o Saggio |
Go to |
| 2005 |
The prognostic role of TP53 mutations in advanced laryngeal squamous cell carcinoma (LSCC). |
Proceedings |
Go to |
| 2005 |
Farmacogenomica nei carcinomi colorettali: prospettive nella terapia personalizzata |
Capitolo o Saggio |
Go to |
| 2005 |
TP53 mutations are not prognostic indipendent indicators in bladder cancer |
Proceedings |
Go to |
| 2005 |
Mutational analysis of BRCA1 gene in sicilian patients at risk for inherited breast and/or ovarian cancer: experience of reference centre for the biomolecular characterization of neoplasms and genetic screening of hereditary tumors. |
Proceedings |
Go to |
| 2005 |
Analysis of Ki-ras mutations in stage I rectal carcinomas and respective regional lymphonodes |
Proceedings |
Go to |
| 2004 |
TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome |
Articolo in rivista |
Go to |
| 2004 |
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations |
Articolo in rivista |
Go to |
| 2004 |
Fattori Predittivi di Risposta ai Citostatici nei Tumori del Tratto Gastrointestinale |
Capitolo o Saggio |
Go to |
| 2004 |
DNA aneuploidy, high SPF and specific p53 mutations are independent prognostic factors in colorectale cancer (CRC) |
Proceedings |
Go to |
| 2004 |
Detection and clinical relevance of free circulating tumor DNA in blood of patients with gastrointestinal cancer |
Proceedings |
Go to |
| 2004 |
DNA-Aneuploidy, High SPF and Specific P53 Mutations are Indipendent Prognostic Factors in Colorectal Cancer (CRC) |
Proceedings |
Go to |
| 2004 |
DNA-aneuploidy and high SPF and specific p53 mutations are independent prognostic factors in colorectal cancer (CRC). |
Proceedings |
Go to |
| 2004 |
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer |
Proceedings |
Go to |
| 2004 |
Role of K-RAS and P53 Gene in Salivary Glands Tumorigenesis |
Proceedings |
Go to |
| 2004 |
Detection and clinical relevance of free-circulating tumor DNA in blood of patients with colorectal cancer. Proceeding of ICACT Fifteenth International Congress on Anticancer Treatment February 9th 12th 2004, Paris accepted for oral presentation |
Proceedings |
Go to |
| 2003 |
STAT Proteins: From Normal Control of Cellular Events to Tumorigenesis |
Articolo in rivista |
Go to |
| 2002 |
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer? |
Articolo in rivista |
Go to |
| 2002 |
p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: A prospective study with a five-year follow-up |
Articolo in rivista |
Go to |
| 2002 |
Ras family genes: An interesting link between cell cycle and cancer |
Articolo in rivista |
Go to |
| 2002 |
DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study |
Articolo in rivista |
Go to |
| 2002 |
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype |
Articolo in rivista |
Go to |
| 2002 |
Prognostic significance of p16INK4a alterations and 9p21 loss of heterozigosity in locally advanced laryngeal squamous cell carcinoma |
Articolo in rivista |
Go to |
| 2001 |
Differential expression levels of urokinase-type plasminogen activator and cathepsin D in locally advanced laryngeal squamous cell carcinoma: Clinical implications |
Articolo in rivista |
Go to |
| 2001 |
Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study |
Articolo in rivista |
Go to |
| 2001 |
DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: Results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study |
Articolo in rivista |
Go to |
| 2000 |
Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma |
Articolo in rivista |
Go to |
| 2000 |
Hereditary common cancers: Molecular and clinical genetics |
Articolo in rivista |
Go to |
| 1996 |
Biological characterization of laryngeal squamous-cell carcinoma |
Articolo in rivista |
Go to |
| 1995 |
Cathepsin D content in colorectal cancer |
Articolo in rivista |
Go to |
| 1995 |
Flow cytometric DNA analysis and lysosomal cathepsins b and l in locally advanced laryngeal cancer. Relationship with clinicopathologic parameters and prognostic significance |
Articolo in rivista |
Go to |
| 1994 |
Cathepsin D activity levels in colorectal cancer: Correlation with cathepsin B and L and other biological and clinical parameters |
Articolo in rivista |
Go to |
